• Executive Summary o Market Overview • Market Landscape o Market ecosystem o Market characteristics o Value chain analysis • Market Sizing o Market definition o Market segment analysis o Market size 2020 o Market outlook: Forecast for 2020 - 2025 • Five Forces Analysis o Five forces summary o Bargaining power of buyers o Bargaining power of suppliers o Threat of new entrants o Threat of substitutes o Threat of rivalry o Market condition • Market Segmentation by Application o Market segments o Comparison by Application o Diagnostics - Market size and forecast 2020-2025 o Drug discovery - Market size and forecast 2020-2025 o Other applications - Market size and forecast 2020-2025 o Market opportunity by Application • Customer landscape • Geographic Landscape o Geographic segmentation o Geographic comparison o North America - Market size and forecast 2020-2025 o Europe - Market size and forecast 2020-2025 o Asia - Market size and forecast 2020-2025 o ROW - Market size and forecast 2020-2025 o Key leading countries o Market opportunity by geography o Market drivers o Market challenges o Market trends • Vendor Landscape o Vendor landscape o Landscape disruption o Competitive scenario • Vendor Analysis o Vendors covered o Market positioning of vendors o Abbott Laboratories o Agilent Technologies Inc. o Bio SB o Danaher Corp. o F. Hoffmann-La Roche Ltd. o Merck KGaA o PerkinElmer Inc. o PHC Holdings Corporation • Appendix o Scope of the report o Currency conversion rates for US$ o Research methodology o List of abbreviations Exhibit • 1: Key Finding 1 • 2: Key Finding 2 • 3: Key Finding 3 • 4: Key Finding 5 • 5: Key Finding 6 • 6: Key Finding 7 • 7: Key Finding 8 • 8: Parent market • 9: Market characteristics • 10: Offerings of vendors included in the market definition • 11: Market segments • 12: Global - Market size and forecast 2020 - 2025 ($ million) • 13: Global market: Year-over-year growth 2020 - 2025 (%) • 14: Five forces analysis 2020 & 2025 • 15: Bargaining power of buyers • 16: Bargaining power of suppliers • 17: Threat of new entrants • 18: Threat of substitutes • 19: Threat of rivalry • 20: Market condition - Five forces 2020 • 21: Application - Market share 2020-2025 (%) • 22: Comparison by Application • 23: Diagnostics - Market size and forecast 2020-2025 ($ million) • 24: Diagnostics - Year-over-year growth 2020-2025 (%) • 25: Drug discovery - Market size and forecast 2020-2025 ($ million) • 26: Drug discovery - Year-over-year growth 2020-2025 (%) • 27: Other applications - Market size and forecast 2020-2025 ($ million) • 28: Other applications - Year-over-year growth 2020-2025 (%) • 29: Market opportunity by Application • 30: Customer landscape • 31: Market share by geography 2020-2025 (%) • 32: Geographic comparison • 33: North America - Market size and forecast 2020-2025 ($ million) • 34: North America - Year-over-year growth 2020-2025 (%) • 35: Europe - Market size and forecast 2020-2025 ($ million) • 36: Europe - Year-over-year growth 2020-2025 (%) • 37: Asia - Market size and forecast 2020-2025 ($ million) • 38: Asia - Year-over-year growth 2020-2025 (%) • 39: ROW - Market size and forecast 2020-2025 ($ million) • 40: ROW - Year-over-year growth 2020-2025 (%) • 41: Key leading countries • 42: Market opportunity by geography ($ million) • 43: Impact of drivers and challenges • 44: Vendor landscape • 45: Landscape disruption • 46: Industry risks • 47: Vendors covered • 48: Market positioning of vendors • 49: Abbott Laboratories - Overview • 50: Abbott Laboratories - Business segments • 51: Abbott Laboratories - Key offerings • 52: Abbott Laboratories - Key customers • 53: Abbott Laboratories - Segment focus • 54: Agilent Technologies Inc. - Overview • 55: Agilent Technologies Inc. - Business segments • 56: Agilent Technologies Inc. - Key offerings • 57: Agilent Technologies Inc. - Key customers • 58: Agilent Technologies Inc. - Segment focus • 59: Becton, Dickinson and Co. - Overview • 60: Becton, Dickinson and Co. - Business segments • 61: Becton, Dickinson and Co. - Key offerings • 62: Becton, Dickinson and Co. - Key customers • 63: Becton, Dickinson and Co. - Segment focus • 64: Bio SB - Overview • 65: Bio SB - Product and service • 66: Bio SB - Key offerings • 67: Bio SB - Key customers • 68: Bio SB - Segment focus • 69: Bio-Rad Laboratories, Inc - Overview • 70: Bio-Rad Laboratories, Inc - Business segments • 71: Bio-Rad Laboratories, Inc - Key offerings • 72: Bio-Rad Laboratories, Inc - Key customers • 73: Bio-Rad Laboratories, Inc - Segment focus • 74: Danaher Corp. - Overview • 75: Danaher Corp. - Business segments • 76: Danaher Corp. - Key offerings • 77: Danaher Corp. - Key customers • 78: Danaher Corp. - Segment focus • 79: F. Hoffmann-La Roche Ltd. - Overview • 80: F. Hoffmann-La Roche Ltd. - Business segments • 81: F. Hoffmann-La Roche Ltd. - Key offerings • 82: F. Hoffmann-La Roche Ltd. - Key customers • 83: F. Hoffmann-La Roche Ltd. - Segment focus • 84: Merck KGaA - Overview • 85: Merck KGaA - Business segments • 86: Merck KGaA - Key offerings • 87: Merck KGaA - Key customers • 88: Merck KGaA - Segment focus • 89: PerkinElmer Inc. - Overview • 90: PerkinElmer Inc. - Business segments • 91: PerkinElmer Inc. - Key offerings • 92: PerkinElmer Inc. - Key customers • 93: PerkinElmer Inc. - Segment focus • 94: PHC Holdings Corporation - Overview • 95: PHC Holdings Corporation - Product and service • 96: PHC Holdings Corporation - Key offerings • 97: PHC Holdings Corporation - Key customers • 98: PHC Holdings Corporation - Segment focus • 99: Currency conversion rates for US$ • 100: Research Methodology • 101: Validation techniques employed for market sizing • 102: Information sources • 103: List of abbreviations

Abbott Laboratories, Agilent Technologies Inc., Becton, Dickinson and Co., Bio SB, Bio-Rad Laboratories, Inc, Danaher Corp., F. Hoffmann-La Roche Ltd., Merck KGaA, PerkinElmer Inc., PHC Holdings Corporation